Fragment-Based Discovery of 7-Azabenzimidazoles as Potent, Highly Selective, and Orally Active CDK4/6 Inhibitors

被引:38
作者
Cho, Young Shin [1 ]
Angove, Hayley [2 ]
Brain, Christopher [1 ]
Chen, Christine Hiu-Tung [1 ]
Cheng, Hong [1 ]
Cheng, Robert [2 ]
Chopra, Rajiv [1 ]
Chung, Kristy [1 ]
Congreve, Miles [2 ]
Dagostin, Claudio [2 ]
Davis, Deborah J. [2 ]
Felten, Ruth [2 ]
Giraldes, John [1 ]
Hiscock, Steven D. [2 ]
Kim, Sunkyu [1 ]
Kovats, Steven [1 ]
Lagu, Bharat [1 ]
Lewry, Kim [2 ]
Loo, Alice [1 ]
Lu, Yipin [1 ]
Luzzio, Michael [1 ]
Maniara, Wiesia [1 ]
McMenamin, Rachel [2 ]
Mortenson, Paul N. [2 ]
Benning, Rajdeep [2 ]
O'Reilly, Marc [2 ]
Rees, David C. [2 ]
Shen, Junqing [1 ]
Smith, Troy [1 ]
Wang, Yaping [1 ]
Williams, Glyn [2 ]
Woolford, Alison J. -A. [2 ]
Wrona, Wojciech [1 ]
Xu, Mei [1 ]
Yang, Fan [1 ]
Howard, Steven [2 ]
机构
[1] Novartis Inst Biomed Res, Cambridge, MA 02139 USA
[2] Astex Pharmaceut Inc, Cambridge CB4 0QA, England
来源
ACS MEDICINAL CHEMISTRY LETTERS | 2012年 / 3卷 / 06期
关键词
CDK4/6; pRb phosphorylation; mantle cell lymphoma; fragment-based screening; structure-guided optimization; MANTLE CELL LYMPHOMA; RETINOBLASTOMA PROTEIN; GENETIC ALGORITHM; CANCER; CYCLE; INACTIVATION;
D O I
10.1021/ml200241a
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Herein, we describe the discovery of potent and highly selective inhibitors of both CDK4 and CDK6 via structure-guided optimization of a fragment-based screening hit. CDK6 X-ray crystallography and pharmacokinetic data steered efforts in identifying compound 6, which showed >1000-fold selectivity for CDK4 over CDKs 1 and 2 in an enzymatic assay. Furthermore, 6 demonstrated in vivo inhibition of pRb-phosphorylation and oral efficacy in a Jeko-1 mouse xenograft model.
引用
收藏
页码:445 / 449
页数:5
相关论文
共 26 条
  • [1] Amin HM, 2003, ARCH PATHOL LAB MED, V127, P424
  • [2] 4-(Pyrazol-4-yl)-pyrimidines as Selective Inhibitors of Cyclin-Dependent Kinase 4/6
    Cho, Young Shin
    Borland, Maria
    Brain, Christopher
    Chen, Christine H. -T
    Cheng, Hong
    Chopra, Rajiv
    Chung, Kristy
    Groarke, James
    He, Guo
    Hou, Ying
    Kim, Sunkyu
    Kovats, Steven
    Lu, Yipin
    O'Reilly, Marc
    Shen, Junqing
    Smith, Troy
    Trakshel, Gary
    Voegtle, Markus
    Xu, Mei
    Xu, Ming
    Sung, Moo Je
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (22) : 7938 - 7957
  • [3] Crystal structure of human CDK4 in complex with a D-type cyclin
    Day, Philip J.
    Cleasby, Anne
    Tickle, Ian J.
    O'Reilly, Marc
    Coyle, Joe E.
    Holding, Finn P.
    McMenamin, Rachel L.
    Yon, Jeff
    Chopra, Rajiv
    Lengauer, Christoph
    Jhoti, Harren
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (11) : 4166 - 4170
  • [4] Fry DW, 2004, MOL CANCER THER, V3, P1427
  • [5] Recent advances in the development of selective small molecule inhibitors for cyclin-dependent kinases
    Hirai, H
    Kawanishi, N
    Iwasawa, Y
    [J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2005, 5 (02) : 167 - 179
  • [6] A novel approach for the development of selective Cdk4 inhibitors: Library design based on locations of Cdk4 specific amino acid residues
    Honma, T
    Yoshizumi, T
    Hashimoto, N
    Hayashi, K
    Kawanishi, N
    Fukasawa, K
    Takaki, T
    Ikeura, C
    Ikuta, M
    Suzuki-Takahashi, I
    Hayama, T
    Nishimura, S
    Morishima, H
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (26) : 4628 - 4640
  • [7] Ligand efficiency: a useful metric for lead selection
    Hopkins, AL
    Groom, CR
    Alex, A
    [J]. DRUG DISCOVERY TODAY, 2004, 9 (10) : 430 - 431
  • [8] MOLECULAR RECOGNITION OF RECEPTOR-SITES USING A GENETIC ALGORITHM WITH A DESCRIPTION OF DESOLVATION
    JONES, G
    WILLETT, P
    GLEN, RC
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1995, 245 (01) : 43 - 53
  • [9] Development and validation of a genetic algorithm for flexible docking
    Jones, G
    Willett, P
    Glen, RC
    Leach, AR
    Taylor, R
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1997, 267 (03) : 727 - 748
  • [10] A CELL-CYCLE REGULATOR POTENTIALLY INVOLVED IN GENESIS OF MANY TUMOR TYPES
    KAMB, A
    GRUIS, NA
    WEAVERFELDHAUS, J
    LIU, QY
    HARSHMAN, K
    TAVTIGIAN, SV
    STOCKERT, E
    DAY, RS
    JOHNSON, BE
    SKOLNICK, MH
    [J]. SCIENCE, 1994, 264 (5157) : 436 - 440